Oramed Pharmaceuticals Inc (ORMP NASDAQ) stock market data APIs
$4.2793
-0.08(-1.9%)
as of August 11, 2026
Try our APIs with
free plan!
Oramed Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Prev. Close
4.2793
Open
4.2035
High
4.3728
Low
4.1807
52 wk Range
1.8412-5.19
Market Cap
177 M
P/E Ratio
1.6346
Shares Outstanding
41 597 K
EPS
-0.09
Dividends (Yield)
0
Beta
1.158
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Oramed Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Oramed Pharmaceuticals Inc data using free add-ons & libraries
Get Oramed Pharmaceuticals Inc Fundamental Data
Oramed Pharmaceuticals Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -14 402 000
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Oramed Pharmaceuticals Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-10
- EPS/Forecast: 0.43
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Oramed Pharmaceuticals Inc News
New
Top Biotech Gainers: TECH Bought Out, MSLE On Watch, KYMR Hits New High, What's The Buzz At SLS?
(RTTNews) - Today's top gainers in the biotech space include Bio-Techne, following acquisition news; Satellos Bioscience, gearing up to present new DMD data next month; and Kymera, which has revised i...
Oramed Pharmaceuticals And Two Other Promising Penny Stocks For Savvy Investors
The market has shown impressive growth, with a 4.2% increase over the last week and a 29% rise over the past year, while earnings are projected to grow by 16% annually. Although the term 'penny stock'...
Lifeward Successfully Closes on Strategic Partnership with Oramed
HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to tr...
Top 10 healthcare stocks with highest dividend yield amid volatile markets
[Markets Open Down On Jobs Reports Data And Iran War Uncertainty, Day After Steep Decline] Michael M. Santiago/Getty Images News As broader markets grapple with geopolitical uncertainty, oil prices a...
Get Oramed Pharmaceuticals Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
